Stock of the Day: Nuvectra Corp’s Trend Down, Especially After Today’s Weak Session

Stock of the Day: Nuvectra Corp's Trend Down, Especially After Today's Weak Session

The stock of Nuvectra Corp (NASDAQ:NVTR) is a huge mover today! The stock decreased 4.77% or $0.33 during the last trading session, hitting $6.59. About 54,335 shares traded hands. Nuvectra Corp (NASDAQ:NVTR) has risen 6.00% since September 4, 2016 and is uptrending. It has underperformed by 6.22% the S&P500.
The move comes after 7 months negative chart setup for the $70.80M company. It was reported on Oct, 4 by We have $5.87 PT which if reached, will make NASDAQ:NVTR worth $7.79M less.

Analysts await Nuvectra Corp (NASDAQ:NVTR) to report earnings on November, 9. After $-0.85 actual earnings per share reported by Nuvectra Corp for the previous quarter, Wall Street now forecasts -7.06% EPS growth.

According to Zacks Investment Research, “Nuvectra Corporation develops and commercializes neuromodulation medical device for the treatment of nervous system disorders. It also provides neural interface technology, components and systems, as well as NeuroNexus SmartBox portable control and data streaming systems. Nuvectra Corporation is based in Plano, Texas.”

More notable recent Nuvectra Corp (NASDAQ:NVTR) news were published by: which released: “/quotes/zigman/3870025/realtime” on December 30, 2013, also with their article: “Nuvectra: Somewhere Joel Greenblatt Is Smiling” published on April 12, 2016, published: “Nuvectra: An Attractive Spinoff Trading Near Liquidation Value” on May 13, 2016. More interesting news about Nuvectra Corp (NASDAQ:NVTR) were released by: and their article: “Greatbatch (GB) Completes Spin-off of Nuvectra (NVTR)” published on March 14, 2016 as well as‘s news article titled: “Greatbatch, Inc. Files Form 10 for Its Proposed Nuvectra Spin-Off” with publication date: July 30, 2015.

NVTR Company Profile

Nuvectra Corporation, formerly QIG Group, LLC, is a neurostimulation company. The Firm is focused on the development and commercialization of a neurostimulation technology platform. The Company’s neurostimulation technology platform is used for the treatment of various disorders through stimulation of tissues associated with the nervous system. The Company’s Algovita spinal cord stimulation (SCS) system is an application of its neurostimulation technology platform, and is used for the treatment of chronic pain of the trunk and limbs.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment